The role of animal models in evaluating reasonable safety and efficacy for human trials of cell-based interventions for neurologic conditions

Alan Regenberg, Debra J.H. Mathews, David M. Blass, Hilary Bok, Joseph T. Coyle, Patrick Duggan, Ruth Faden, Julia Finkel, John D. Gearhart, Argye Hillis, Ahmet Hoke, Richard Johnson, Michael Johnston, Jeffrey Kahn, Douglas Kerr, Patricia King, Joanne Kurtzberg, S. Matthew Liao, John W. McDonald, Guy McKhannKarin B. Nelson, Mahendra Rao, Andrew W. Siegel, Kirby Smith, Davor Solter, Hongjun Song, Jeremy Sugarman, Angelo Vescovi, Wise Young, Henry T. Greely, Richard J. Traystman

Research output: Contribution to journal › Review article › peer-review

Fingerprint

Dive into the research topics of 'The role of animal models in evaluating reasonable safety and efficacy for human trials of cell-based interventions for neurologic conditions'. Together they form a unique fingerprint.

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

Keyphrases